1062 related articles for article (PubMed ID: 11280755)
21. Patterns of costimulation of T cell clones by cross-linking CD3, CD4/CD8, and class I MHC molecules.
Wacholtz MC; Patel SS; Lipsky PE
J Immunol; 1989 Jun; 142(12):4201-12. PubMed ID: 2470819
[TBL] [Abstract][Full Text] [Related]
22. CD28-mediated costimulation is necessary for the activation of T cell receptor-gamma delta+ T lymphocytes.
Sperling AI; Linsley PS; Barrett TA; Bluestone JA
J Immunol; 1993 Dec; 151(11):6043-50. PubMed ID: 8245449
[TBL] [Abstract][Full Text] [Related]
23. Comparison of CD28-B7.1 and B7.2 functional interaction in resting human T cells: phosphatidylinositol 3-kinase association to CD28 and cytokine production.
Ghiotto-Ragueneau M; Battifora M; Truneh A; Waterfield MD; Olive D
Eur J Immunol; 1996 Jan; 26(1):34-41. PubMed ID: 8566081
[TBL] [Abstract][Full Text] [Related]
24. Immunogenicity of biliary epithelium: investigation of antigen presentation to CD4+ T cells.
Leon MP; Bassendine MF; Wilson JL; Ali S; Thick M; Kirby JA
Hepatology; 1996 Sep; 24(3):561-7. PubMed ID: 8781325
[TBL] [Abstract][Full Text] [Related]
25. Ligation of CD28 on resting T cells by its ligand B7 results in the induction of both Th1- and Th2-type cytokines.
Walter H; Schepensn S; Van Wauwe J; de Boer M
Eur Cytokine Netw; 1994; 5(1):13-21. PubMed ID: 7519453
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-12 can replace CD28-dependent T-cell costimulation during nonspecific cytotoxic T lymphocyte induction by anti-CD3 antibody.
Makrigiannis AP; Musgrave BL; Haeryfar SM; Hoskin DW
J Leukoc Biol; 2001 Jan; 69(1):113-22. PubMed ID: 11200055
[TBL] [Abstract][Full Text] [Related]
27. An anti-CD30 chimeric receptor that mediates CD3-zeta-independent T-cell activation against Hodgkin's lymphoma cells in the presence of soluble CD30.
Hombach A; Heuser C; Sircar R; Tillmann T; Diehl V; Pohl C; Abken H
Cancer Res; 1998 Mar; 58(6):1116-9. PubMed ID: 9515791
[TBL] [Abstract][Full Text] [Related]
28. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN
Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355
[TBL] [Abstract][Full Text] [Related]
29. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
[TBL] [Abstract][Full Text] [Related]
30. B7.1 is a quantitatively stronger costimulus than B7.2 in the activation of naive CD8+ TCR-transgenic T cells.
Fields PE; Finch RJ; Gray GS; Zollner R; Thomas JL; Sturmhoefel K; Lee K; Wolf S; Gajewski TF; Fitch FW
J Immunol; 1998 Nov; 161(10):5268-75. PubMed ID: 9820499
[TBL] [Abstract][Full Text] [Related]
31. IL-2-independent activation and proliferation in human T cells induced by CD28.
Boulougouris G; McLeod JD; Patel YI; Ellwood CN; Walker LS; Sansom DM
J Immunol; 1999 Aug; 163(4):1809-16. PubMed ID: 10438913
[TBL] [Abstract][Full Text] [Related]
32. Evidence for intact costimulation via CD28 and CD27 molecules in hyporesponsive T cells from human immunodeficiency virus-infected individuals.
Meyaard L; Kuiper H; Otto SA; Wolthers KC; van Lier RA; Miedema F
Eur J Immunol; 1995 Jan; 25(1):232-7. PubMed ID: 7531146
[TBL] [Abstract][Full Text] [Related]
33. Evidence for a critical role for IL-2 in CD40-mediated activation of naive B cells by primary CD4 T cells.
Johnson-Léger C; Christenson JR; Holman M; Klaus GG
J Immunol; 1998 Nov; 161(9):4618-26. PubMed ID: 9794390
[TBL] [Abstract][Full Text] [Related]
34. Ligation of the CD5 or CD28 molecules on resting human T cells induces expression of the early activation antigen CD69 by a calcium- and tyrosine kinase-dependent mechanism.
Vandenberghe P; Verwilghen J; Van Vaeck F; Ceuppens JL
Immunology; 1993 Feb; 78(2):210-7. PubMed ID: 7682535
[TBL] [Abstract][Full Text] [Related]
35. T cells engrafted with a recombinant anti-CD30 receptor target autologous CD30(+) cutaneous lymphoma cells.
Hombach A; Muche JM; Gerken M; Gellrich S; Heuser C; Pohl C; Sterry W; Abken H
Gene Ther; 2001 Jun; 8(11):891-5. PubMed ID: 11423937
[TBL] [Abstract][Full Text] [Related]
36. Costimulatory effect of IL-12 on the activation of naive, memory CD4+ T cells, and Th1 clone.
Kato T; Morokata T; Igarashi O; Yee ST; Inobe M; Uede T; Azuma M; Okumura K; Nariuchi H
Cell Immunol; 1997 Feb; 176(1):50-8. PubMed ID: 9070317
[TBL] [Abstract][Full Text] [Related]
37. Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells.
Galea-Lauri J; Darling D; Gan SU; Krivochtchapov L; Kuiper M; Gäken J; Souberbielle B; Farzaneh F
J Immunol; 1999 Jul; 163(1):62-70. PubMed ID: 10384100
[TBL] [Abstract][Full Text] [Related]
38. Stable expression of chimeric anti-CD3 receptors on mammalian cells for stimulation of antitumor immunity.
Liao KW; Chen BM; Liu TB; Tzou SC; Lin YM; Lin KF; Su CI; Roffler SR
Cancer Gene Ther; 2003 Oct; 10(10):779-90. PubMed ID: 14502231
[TBL] [Abstract][Full Text] [Related]
39. A functional role for CD28 costimulation in tumor recognition by single-chain receptor-modified T cells.
Moeller M; Haynes NM; Trapani JA; Teng MW; Jackson JT; Tanner JE; Cerutti L; Jane SM; Kershaw MH; Smyth MJ; Darcy PK
Cancer Gene Ther; 2004 May; 11(5):371-9. PubMed ID: 15060573
[TBL] [Abstract][Full Text] [Related]
40. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
